Fresenius Medical Care (ETR:FME) Change of Rating

Fresenius Medical Care (ETR:FME) was upgraded by Oddo Seydler Bank AG to “Buy” rating in a research note sent to clients and investors on Wednesday morning. The firm currently has EUR 87.00 target price per share on the stock. Oddo Seydler Bank AG’s target is 16.61 % from FME’s last price.

ETR:FME Price Chart & Trend

The stock price of Fresenius Medical Care has increased 0.53% over the last 200 days, and is in shaky up trend. In the last 50 and 100 days, Fresenius Medical Care is down 5.57% and up 3.35%, respectively. Our stocks momentum model is shown on the price chart below.

Source: RightEdge Systems, Yahoo Split & Dividend Adjusted Data and OctaFinance Trading Models

Fresenius Medical Care (ETR:FME) Profile

Fresenius Medical Care AG & Co. KGaA (FMC AG & CO. KGAA) is a kidney dialysis company.

Fresenius Medical Care (ETR:FME) traded down -3.78% on 10 February, hitting EUR 71.77. A total of 864,960 shares of the company’s stock traded hands. This is down from average of 868,156 shares. Fresenius Medical Care has a 52 week low of EUR 62.65 and a 52 week high of EUR 83.17. The company has a market cap of 22.45 billion EUR and a P/E ratio of 23.78.

Get the latest Fresenius Medical Care (ETR:FME) Stock Ratings at Octafinance. Completely free access to our Analyst Ratings Database for 6000+ stocks.

The post Will Oddo Seydler Bank AG Upgrade to “Buy” Be a Tailwind For Fresenius Medical Care (ETR:FME) Stock Today? appeared first on Octafinance.